Oppenheimer analyst Andreas Argyrides initiated coverage of Korro Bio (KRRO) with an Outperform rating and $155 price target
Oppenheimer analyst Andreas Argyrides initiated coverage of Korro Bio (KRRO) with an Outperform rating and $155 price target